工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:FOXP3+ regulatory T cells and the immune escape in solid tumours.
FOXP3+ regulatory T cells and the immune escape in solid tumours.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
FOXP3+调节性T(Treg)细胞在建立免疫抑制性肿瘤微环境中发挥关键作用,这一微环境的形成和动态维持依赖于多种基质细胞和免疫细胞亚群的贡献。然而,非淋巴FOXP3+Treg细胞的动态变化以及Treg细胞与其他细胞类型在实体瘤微环境中的相互调控在很大程度上仍不清楚。在本综述中,我们根据已确立的和新出现的癌症标志,总结了关于非淋巴Treg细胞亚群动态联系和相互调控的最新发现,尤其是在实体瘤中肿瘤细胞免疫逃逸方面。我们对FOXP3+Treg细胞与癌症关键标志之间相互作用的理解,可能为开发下一代基于工程化T细胞的实体瘤免疫治疗提供新的见解。
FOXP3+ regulatory T (Treg) cells play critical roles in establishing the immunosuppressive tumour microenvironment, which is achieved and dynamically maintained with the contribution of various stromal and immune cell subsets.
However, the dynamics of non-lymphoid FOXP3+ Treg cells and the mutual regulation of Treg cells and other cell types in solid tumour microenvironment remains largely unclear. In this review, we summarize the latest findings on the dynamic connections and reciprocal regulations of non-lymphoid Treg cell subsets in accordance with well-established and new emerging hallmarks of cancer, especially on the immune escape of tumour cells in solid tumours.
Our comprehension of the interplay between FOXP3+ Treg cells and key hallmarks of cancer may provide new insights into the development of next-generation engineered T cell-based immune treatments for solid tumours.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。